Danish Batti MD
Movement Disorders Neurologists and teaches physicians internationally, Directs an online mini-fellowship in Movement Disorders since 2017, Founding director of the International Neurology program at University of Nebraska Medical Center
Neuropsychiatric symptoms in Parkinson's Disease
Parkinson's Disease is a neurodegenerative disorder that has historically been seen as a motor disorder. However, there are significant non-motor symptoms in almost all of the patients with PD. Including frequent Psychiatric Co-morbidities both in early and late PD
Tardive Dysknesia is a movement disorder generally induced by anti-psychotic medications. Antipsychotics are a group of drugs used primarily to treat psychosis, schizophrenia, mania and agitation. Extrapyramidal symptoms, which include acute dystonia, akathisia, pseudoparkinsonism and tardive dyskinesia, are the most common side effects of first-generation antipsychotics, but can also occur with second-generation antipsychotics.
Neuroleptic Malignant Syndrome
Neuroleptic Malignant Syndrome (NMS) is a life-threatening neurological disorder requiring emergent care. It is associated with the use of antipsychotic agents also called neuroleptics. The incidence rate for NMS in patients taking antipsychotics is 0.02 to 3%
Myasthenia crisis is a complication of myasthenia gravis. It is defined as worsening of myasthenic weakness requiring intubation or noninvasive ventilation. Myasthenia crisis has a mortality rate of 5%